Table 1.
Treatment Cycle When Cytokine Was Initiated
| Treatment Cycle | Erythropoietin | GCSF |
|---|---|---|
| 1 | 85 | 71 |
| 2 | 101 | 92 |
| 3 | 74 | 119 |
| 4 | 61 | 84 |
| 5 | 54 | 79 |
| 6 | 40 | 48 |
| 7 | 8 | 3 |
| 8 | 3 | 1 |
| 9 | 1 | 0 |
| 12 | 1 | 1 |
|
| ||
| Total | 428 | 498 |
| Fraction and percent of patients initiating ESAs or GCSF by Initial Performance Status | ||
|---|---|---|
| Erythropoietin | ||
| Performance Status | ESA | GCSF |
| 0 | 174/928 (18.7) | 235/928 (25.3) |
| 1 | 209/805 (26.0) | 219/805 (27.2) |
| 2 | 45/131 (34.3) | 44/131 (33.6) |
| Total | 428/1864 | 498/1864 |
| Number of patients initiating GCSF or Erythropoietin during study | |||
|---|---|---|---|
| Erythropoietin | Total | ||
| GCSF | No | Yes | |
| No | 1125(82.4) | 241 (17.6) | 1366 |
| Yes | 311 (62.4) | 187 (37.5) | 498 |
| Total | 1436 | 428 | 1864 |